Geovax Labs Inc (GOVX)
2.45
-0.02
(-0.81%)
USD |
NASDAQ |
Sep 27, 16:00
2.42
-0.03
(-1.22%)
After-Hours: 20:00
Geovax Labs SG&A Expense (Annual): 6.022M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.022M |
| December 31, 2022 | 4.987M |
| December 31, 2021 | 3.577M |
| December 31, 2020 | 2.196M |
| December 31, 2019 | 1.638M |
| December 31, 2018 | 1.647M |
| December 31, 2017 | 1.232M |
| December 31, 2016 | 2.131M |
| December 31, 2015 | 1.430M |
| December 31, 2014 | 1.808M |
| December 31, 2013 | 1.792M |
| December 31, 2012 | 1.753M |
| December 31, 2011 | 2.973M |
| December 31, 2010 | 3.162M |
| Date | Value |
|---|---|
| December 31, 2009 | 2.915M |
| December 31, 2008 | 2.970M |
| December 31, 2007 | 2.784M |
| December 31, 2006 | 0.8433M |
| December 31, 2005 | 0.6552M |
| December 31, 2004 | 0.5248M |
| December 31, 2003 | 0.6766M |
| December 31, 2002 | |
| December 31, 2001 | |
| December 31, 2000 | |
| December 31, 1999 | 4.173M |
| December 31, 1998 | 3.273M |
| December 31, 1997 | 1.485M |
| December 31, 1996 | 1.007M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
1.638M
Minimum
2019
6.022M
Maximum
2023
3.684M
Average
3.577M
Median
2021
SG&A Expense (Annual) Benchmarks
| Emergent BioSolutions Inc | 368.40M |
| Tonix Pharmaceuticals Holding Corp | 34.75M |
| Abbott Laboratories | 10.95B |
| SIGA Technologies Inc | 22.04M |
| Chimerix Inc | 24.60M |